Healty adult
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) An age 30 years or older and up to 60 years, the age shall be the date of informed consent acquisition) 2) Subjects with constipation (functional constipation) whose stool frequency is 10 or less in 2 weeks 3) Subjects who are judged as suitable for the study by the investigotor 4) Those who received sufficient explanation about the purpose of this study and agree to subject in an informed consent
Exclusion criteria
Exclusion criteria: 1) A medical history of severe disorders, which affects absorption, metabolism, excretion in the digestive tract, heart, liver, thyroid gland and kidney, or those subjects who have difficulty in participating in this study of their past medical history 2) Gastrectomy, gastrointestinal sutures, who have major surgery history affects absorption in the gastrointestinal tract site such as intestinal resection 3) Those who have hypersensitivity to drugs or idiosyncrasies 4) Those who have ever suffered from a physical disorder by ingesting a commercially available supplement 5) Alcohol or drug addicts 6) Pregnancy or women of childbearing potential, who wish to become pregnant during lactation or test period 7) Those who are participating in other clinical trials at the start of this study 8) Those who participated in clinical trials of medicines within 16 weeks before this study, or human examination of health food within 8 weeks 9) Those who took medical prescription medicines such as an intestinal tract or the like, which have an effect on constipation treatment etc. within one week before the start of the study 10) Those who collected 400 mL or more of whole blood within 12 weeks before the start of the test 11) In addition, those judged unsuitable as subjects by investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study aim to evaluate the effects of ingestion of food containing LAC for 4 weeks on constipation effect in subjects with bowel movement slower. | — |
Secondary
| Measure | Time frame |
|---|---|
| Efficacy | — |
Countries
Japan
Contacts
Kands R&D Corporation Bord director